Randomized double-blind trial evaluates targeted-release budesonide's effect on primary IgA nephropathy, suggesting potential for improvement.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: